Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease Tekijä Jesiree Iglésias Quadros Distenhreft, Dinair Couto-Lima, Cecilia Siliansky de Andreazzi, Juliana Feu Rosa Carrera Thomazini, Lauro Monteiro Vasconcellos Filho, Aloísio Falqueto, Weverton Machado Luchi

Hae kokoteksti